Redefining Tumor Vascular Permeability through Deep Learning-Guided Microneedle Delivery

View at publisher
Authors: Jingwei Tian, Mingsheng Zhu, Zhenyu Guan, Jianxin Liu, Yuanke Li, Qiqi Liu, Yingqi Miao, Jin Wu, Che Zhou, Xiangyang Wang, Jie Zhuang, Xinglu Huang
Cited by: 1
References: 33

Abstract

Low-permeability (LP) tumor vasculature constitutes a major barrier to efficient nanomedicine delivery, making quantitative assessment and mechanistic understanding of vascular permeability essential for the rational design of delivery strategies. Here, we introduce a deep learning-guided microneedle (MN) delivery platform that enables localized and spatiotemporally precise modulation of tumor vasculature to enhance nanoparticle extravasation. By integrating the MN system with an upgraded single-vessel analysis framework (nano-ISML 1.1), we quantitatively mapped vascular remodeling and nanoparticle transport across diverse tumor types and particle sizes. Localized histamine delivery via MNs selectively expanded endothelial junctions through VE-cadherin-mediated regulation, significantly increasing the frequency and length of interendothelial gaps, and thereby reprogramming LP tumors toward a high-permeability phenotype. This controlled vascular remodeling established a pronounced size-dependent permeability window, defined by locally induced gap dimensions that varied across tumor types, permitting efficient penetration of nanoparticles ≤200 nm while largely excluding particles >500 nm. By uniting nanotechnology, vascular biology, and artificial intelligence, this interdisciplinary framework provides a mechanistic and predictive paradigm for overcoming vascular barriers and advancing the rational design of tumor-targeted nanomedicines.

Fields of Study & Subjects

Nanoplatforms for cancer theranostics Advancements in Transdermal Drug Delivery Nanoparticle-Based Drug Delivery

Publication details

Journal / source
ACS Nano
Publisher
American Chemical Society (ACS)
Volume
20
Issue
7
Pages
5613–5628
Publication date
9 February 2026
Language
EN